Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compound for anti-cancer therapy that acts by targeting GOF mutant P53 and stimulates P73 to restore the P53 pathway signaling

Compound for anti-cancer therapy that acts by targeting GOF mutant P53 and stimulates P73 to restore the P53 pathway signaling

US Patent 10322123 · Granted Jun 18, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prodigiosin analogs and methods of use2025
Frequent EGFR and NTRK somatic mutations in colorectal cancer (CRC) with microsa2024
miR-3132 upregulation of the trail pathway and apoptotic activity in cancer cell2024
Small molecule trail gene induction by normal and tumor cells as an anticancer t2024
Prodigiosin analogs and methods of use2024
Treatment of tumors with miRNA targeting CDK4/CDK62024
miR-3132 upregulation of the TRAIL pathway and apoptotic activity in cancer cell2023
Prodigiosin analogs and methods of use2022
Compounds for repressing cancer cell growth2021
Compounds for repressing cancer cell growth2021
Treatment of tumors with miRNA targeting CDK4/CDK62021
Dual inhibition of CDK and HSP90 destabilize H1F1 α and synergistically induces 2021